You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HSCT, iron overload, deferasirox, labile plasma iron

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Measures to Prevent Liver and Pancreas Complications in

Active, not recruiting
  • Iron Overload
  • Trieste, Italy
    IRCCS Burlo Garofolo
Jan 4, 2022

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)

Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
Jun 1, 2021

Cardiac Iron Overload Trial in Worldwide (Deferasirox and Deferoxamine)

Completed
Has Results
  • Cardiac Iron Overload
  • Deferasirox and Deferoxamine
  • Toronto, Ontario, Canada
  • +14 more
Jul 23, 2021

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Stanford, California
  • +2 more
Jun 1, 2021

Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)

Completed
Has Results
  • Beta-thalassemia
  • Iron Overload
  • Los Angeles, California
  • +2 more
Jun 8, 2021

ß-thalassemia, Transfusional Iron Overload Trial in Cagliari, Genova, Orbassano (Deferasirox)

Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Cagliari, CA, Italy
  • +2 more
Dec 6, 2020

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Endocrine Function During Deferasirox Therapy

Completed
  • Iron Overload
  • +2 more
    • Naples, Italy
      Università degli Studi della Campania Luigi Vanvitelli
    Aug 13, 2020

    Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)

    Completed
    Has Results
    • Chronic Iron Overload
    • Lushnjë, Albania
    • +21 more
    Apr 8, 2021

    Thalassemia Major Trial (n-acetylcystine)

    Not yet recruiting
    • Thalassemia Major
    • (no location specified)
    Mar 9, 2023

    Anemia, Myelodysplastic Syndrome Trial in Seattle (Deferasirox, Laboratory Biomarker Analysis)

    Terminated
    Has Results
    • Anemia
    • Myelodysplastic Syndrome
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 12, 2020

    Iron and Retinopathy of Prematurity (ROP)

    Recruiting
    • Retinopathy of Prematurity
    • Plasma determination of iron, transferrin and ferritin
    • Fundus Examination by wide field digital imaging camera (PanocamTM camera)
    • Paris, France
    • +2 more
    Sep 14, 2022

    Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

    Completed
    • Thalassemia Major
    • New York, New York
    • +3 more
    Jan 31, 2022

    Different Risk Factors on Growth Parameters of Thalassemic

    Not yet recruiting
    • Thalassemia Major
    • serum ferritin and AST
    • (no location specified)
    Mar 29, 2022

    Hyperferritinemia Candidate Gene

    Recruiting
    • Hyperferritinemia
    • Genetic analysis
    • Monza, MB, Italy
      Centre for Rare Disease - Disorders of Iron Metabolism, ASST-Mon
    Jan 17, 2023

    Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

    Recruiting
    • Sickle Cell Disease
    • Deferasirox 360 MG
    • Amsterdam, Meibergdreef 9, Netherlands
      Amsterdan UMC location AMC
    May 23, 2022

    Anemia Trial in Baltimore (sodium ferric gluconate (brand), sodium ferric gluconate (generic))

    Completed
    Has Results
    • Anemia
    • Brand sodium ferric gluconate
    • Generic sodium ferric gluconate
    • Baltimore, Maryland
      University of Maryland
    Sep 5, 2022

    Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

    Terminated
    Has Results
    • Transfusion-dependent β-thalassemia Patients
    • Cardiac Iron Overload
    • Athens, GR, Greece
    • +3 more
    Oct 21, 2019

    Hereditary Hemochromatosis, Hyperferritinemia Trial in Basel, Berne (Venipuncture)

    Enrolling by invitation
    • Hereditary Hemochromatosis
    • Hyperferritinemia
    • Venipuncture
    • Basel, Switzerland
    • +1 more
    Feb 14, 2023

    MDS Trial in Worldwide (Deferasirox, Placebo)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Anaheim, California
    • +71 more
    Oct 30, 2020

    Chronic Iron Overload Trial in Austria, Greece, Italy (Deferasirox)

    Completed
    Has Results
    • Chronic Iron Overload
    • Vienna, Austria
    • +13 more
    Feb 18, 2020

    "Iron Overload and Endocrinological Diseases"

    Recruiting
    • Iron Overload
    • +4 more
      • Modena, Italy
        Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
      Nov 13, 2023

      Chronic Renal Disease, Iron-Deficiency Anemia, Anemia of Chronic Kidney Disease Trial in Rio de Janeiro (Ferrous sulfate)

      Active, not recruiting
      • Chronic Renal Disease
      • +3 more
      • Ferrous sulfate
      • Rio de Janeiro, RJ, Brazil
        Denise Mafra
      Sep 15, 2022

      Insulin Secretion Trial in Vellore (Ferrous sulphate)

      Completed
      • Insulin Secretion
      • Ferrous sulphate
      • Vellore, Tamil Nadu, India
        Christian Medical College
      Feb 11, 2022